Delivery Order SPE2DB22D2206-SPE2DB24FJX45

Award Date 8/21/24
Potential Completion Date 9/12/24
Potential Value $110K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $66,245.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract involves the delivery of DARZALEX FASPRO, a pharmaceutical product, with an ultimate completion date of October 3, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, has been awarded multiple indefinite delivery...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA), a defense agency, for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML pharmaceutical products. The $110,408.40 firm fixed-price delivery order has an ultimate completion date of August 20, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,204.20 delivery order contract is for the supply of DARZALEX FASPRO, a 1,800mg/30,000 15ml specialty pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of November 14, 2024. This award is associated with Amerisourcebergen's larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $82,685.76, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 6, 2022 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a...
This federal contract award, valued at $110,408.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DARZALEX FASPRO, a specialty medication, and is a Firm Fixed Price Delivery Order that runs through November 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical,...
This federal contract award, valued at $16,561.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty medication. The contract is a delivery order with a firm fixed price, and the ultimate completion date is October 15, 2024. The award does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $57,112.20, is for the delivery of DARZALEX FASPRO 1,800MG-30,000 15ML, a specialty pharmaceutical product, to support military healthcare programs. This award is not set aside for any specific business category. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,960.42 firm fixed-price delivery order is for the pharmaceutical product DARZALEX FASPRO 1,800MG-30,000 15ML. The contract has a period of performance through July 8, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,802.10 firm fixed-price delivery order contract is for the supply of DARZALEX FASPRO, a pharmaceutical product, with a performance period extending until July 8, 2025. The contract is not set aside and involves open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $110,408.40 firm fixed-price delivery order contract is for the supply of DARZALEX FASPRO 1,800 mg/30,000 15 mL, a specialty medication. The contract has an ultimate completion date of September 12, 2024 and was awarded on August 21, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJX45
    Delivery Order

This federal contract award, valued at $110,408.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DARZALEX FASPRO, a specialty medication, with an ultimate completion date of September 12, 2024.

Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop Support Medical for a comprehensive range of medical commodities, and a $750,000 IDC with the Department of Justice Federal Bureau of Investigation for pharmaceutical products and medical supplies. These IDCs enable efficient procurement of essential pharmaceutical and medical supplies to support military, veterans, and other federal healthcare programs. The contract award has no set-aside designation.

Generated 11/20/24, 9:15 AM